In case of Alzheimer’s disease GSK-3α is involved in the regulation of amyloid processing (Phiel et al. 2003) and insulin was demonstrated facilitating its non-amyloidogenic pathway (Solano et al. 2000). The gene discussed is INS; the disease is Alzheimer disease.